Cancer is a global health problem, with developing countries facing substantial challenges in handling this disease due to restricted entry to advanced treatment plans and economic constraints. Honey, a natural product with diverse therapeutic properties, has proven promise in most cancer prevention and treatment. Its bioactive compounds, along with flavonoids, phenolic acids, and enzymes, own antioxidant, anti-inflammatory, and anti-tumorigenic homes, which could supplement conventional cancer treatments. This sustainable, value-powerful technique is especially superb for developing countries, where access to cutting-edge therapies remains limited. This study suggests that honey can modulate multiple molecular pathways concerned with most cancer development, including apoptosis, cell cycle law, and angiogenesis. It also has the potential to decrease the aspect consequences of chemotherapy and radiation, thereby improving affected person effects. Furthermore, honey's affordability and wide availability in many developing international locations make it a viable option to include in integrative oncology practices. This paper explores the connection between honey and most cancer treatments, highlighting its potential as an accessory therapy, especially in resource-confined settings. The usage of honey is a sustainable and handy technique, supporting global efforts to beautify cancer care fairness. Similarly, this study wants to standardize its utility, dosage, and effectiveness in diverse cancer kinds.